Par Pharmaceutical Companies Cash Flow
Pro Data Export- Quarterly: September 2011 - June 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 | 2009-09 | 2009-06 |
| Net Income | 21.93M | 9.05M | -108.97M | 17.50M | 30.53M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 5.61M | 6.14M | 6.24M | 8.31M | 6.16M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 4.16M | 47.66M | -2.43M | 2.85M | 9.29M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 9.77M | 53.80M | 3.81M | 11.16M | 15.45M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | 27.44M | -9.97M | -35.92M | -8.10M | -5.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Changes in Assets/Liabilities | -118.23M | -5.01M | 146.94M | -13.45M | -1.95M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | 0.27M | 0.29M | 0.22M | 0.81M | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Operating Activities | -86.27M | 58.14M | 42.00M | 16.02M | 44.04M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 | 2009-09 | 2009-06 |
| Capital Expenditures | -2.03M | -1.96M | -3.63M | -1.95M | -3.61M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | 7.38M | -10.60M | -0.81M | 14.19M | 8.26M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 | 2009-09 | 2009-06 |
| Net Cash from Investing Activities | 4.95M | -13.01M | -4.44M | 11.54M | -1.34M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | 0.00 | -47.75M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||
| Equity Issued | -0.00M | 4.78M | -1.87M | 11.94M | 7.27M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | 0.28M | 0.92M | 1.80M | 2.09M | -0.39M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Financing Activities | 0.28M | 5.71M | -0.06M | 14.04M | -40.87M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | -81.04M | 50.84M | 37.50M | 41.59M | 1.83M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 307.01M | 256.17M | 218.67M | 177.08M | 175.25M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 225.97M | 307.01M | 256.17M | 218.67M | 177.08M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
